AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS) - Concepedia

Concepedia

Publication | Open Access

AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)

DOI Full Paper Access

21

Citations

0

References

2018

Year

Caicun Zhou, M. Wang, Ying Cheng, Y. Chen, Yanqiu Zhao, Yuankai Shi, Myung‐Ju Ahn, You Lü, Meiqi Shi, J. Y. Han,

Annals of Oncology

No additional data available for this publication yet. Check back later!